Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

AXA Framlington UK Smaller Companies R Acc

Ranked 12 out of 50 in - UK Smaller Companies over 12 months
All calculations are in GBP unless stated

Managed by

Dan Harlow

Dan Harlow is a fund manager at AXA Investment Managers based in London where he deals in UK small-caps using a growth investment style. Dan joined the firm in 2010 and prior to this he was a fund manager at Montanaro Asset Management. Dan graduated from the University of Southampton with a degree in History.


The Fund invests in shares of UK listed companies which the fund manager believes will provide above-average returns. The Fund invests primarily in small companies. The fund manager selects shares based upon analysis of a company's financial status, quality of its management, expected profitability and prospects for growth.

Showing fund performance in United Kingdom View performance globally


UK Smaller Companies over : 31/01/2017 - 31/01/2018

Total Return

Quarterly Performance

to 01/01/2018 Annual Q1 Q2 Q3 Q4
2017 30.5% 7.3% 7.8% 6.8% 5.6%
2016 5.1% -1.9% -9.7% 15.3% 2.9%
2015 21.9% 4.4% 8.8% 2.8% 4.4%
2014 5.8% 5.0% -4.5% 0.9% 4.5%
2013 43.2% 12.1% -0.3% 13.7% 12.8%
2012 23.7% 11.4% -3.8% 10.3% 4.7%
2011 -0.9% 5.8% 3.5% -11.1% 1.8%
2010 32.3% 4.3% -4.7% 15.2% 15.6%
2009 50.2% -2.5% 28.8% 22.6% -2.4%
2008 -49.2% -13.0% 1.1% -20.9% -27.0%
2007 -8.6% 4.6% 8.1% -10.1% -10.1%
2006 17.9% 15.3% -5.4% 1.4% 6.7%
2005 24.1% 13.8% -1.3% 12.4% -1.6%
2004 33.8% 11.9% -1.2% 1.7% 19.0%
2003 54.1% -10.8% 31.0% 20.8% 9.2%
2002 -19.0% 2.6% -6.0% -21.9% 7.6%
2001 -23.9% 24.5%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date09/04/2001
  • Share Class size312Mn
  • Base currencyGBP
  • ISIN GB0030310857

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment50


  • Annual management1.50%
  • Initial investment0

Related News

Adviser Profile: Simon Landale of Lycetts

Simon Landale is aiming to make charity-owned Lycetts the most ethical IFA in the country, drawing on a huge database of potential clients and attracting socially minded staff

Small caps suffer in sell-off but potential remains

UK smaller companies have underperformed recently but hold out promise for the long term

Montanaro UK small cap manager joins AXA Framlington

AXA Investment Managers has hired Montanaro UK Smaller Companies investment trust manager Dan Harlow for its AXA Framlington investment arm.

Boost for Roger Whiteoak as Rensburg Sheppards beats market

Investment services and fund manager Rensburg Sheppards is growing faster than its competitors and has improved profit margins.

Performance Highlights: Stars profit from Geldof’s soaring firm

Bob Geldof’s media production company Ten Alps has delivered some handsome profits for New Star’s Select Opportunities manager Patrick Evershed.

Fund manager of the Day – AA Rated Roger Whiteoak

Roger Whiteoak is a growth investor who looks for economic themes first and then selects the companies he feels best placed to exploit them.

Broadband wars leave shrewdies reeling

Carphone Warehouse’s aggressive move into the broadband market hit the share price of broadband supplier Plusnet and a bevy of its shrewd shareholders.

AAA-rated manager’s happy Accident

Accident Exchange Group’s share price has risen meteorically since last summer and two Citywire AAA-rated smaller companies specialists have profited from the shares’ ascent from a low of 225p in June.

Tip Update: Cambrian attracts yet more shrewd money

Two top Framlington fund managers have bought more shares in Cambrian Mining ahead of what its chief executive claims will be a 'substantially better' year than the one just ended with a vastly improved profit and maiden dividend.

BrainsTrust News: Ark Therapeutics floats higher on Cerepro progress

Shares in BrainsTrust Small Cap stock and Citywire tip Ark Therapeutics are up by 4% on news of strong progress for two of its most promising drugs, giving a lift to Framlington's Roger Whiteoak.


Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).